Advertisement

Search Results for "Fluocinolone Acetonide Ointment Usp 0 025"

16:29 EDT 22nd May 2013 | BioPortfolio

Matching Channels

None

Matching News

Alimera accretes approvals for Iluvien in 'Fertile' Europe, as FDA doubts continue

Alimera's Iluvien (fluocinolone acetonide) for diabetic macular oedema (fluocinolone acetonide) has won approval from Portugal's medicines regulator, Infarmed, through the decentralised regulatory pro...

Portugal OKs fluocinolone acetonide implant

Portugal’s National Authority of Medicines and Health Products has granted marketing authorization to Alimera Science’s proprietary preparation of 190 µg fluocinolone...

Fluocinolone acetonide implant gets German marketing OK

An intravitreal implant that delivers sub-microgram levels of fluocinolone acetonide for up to 36 months (Iluvien, Alimera Sciences Inc.), has been granted marketing authorization by the Federal M...

Fluocinolone acetonide implant gets German marketing approval

An intravitreal implant that delivers sub-microgram levels of fluocinolone acetonide for up to 36 months (Iluvien, Alimera Sciences Inc.), has been granted marketing authorization by the Federal M...

Fluocinolone inserts helpful in diabetic macular edema

NEW YORK (Reuters Health) - In patients with diabetic macular edema (DME), fluocinolone acetonide (FAc) vitreous inserts worked well for up to three years in a recent study.

UK accepts additional data for DME implant

Pseudophakic patients may benefit from a fluocinolone acetonide intravitreal implant (Iluvien, Alimera Sciences), the company tells a United Kingdom committee.

NICE rebuffs Alimera's Iluvien for DME

Alimera Sciences Inc. (NASDAQ:ALIM) fell $0.39 (14%) to $2.41 on Wednesday after the U.K.'s NICE issued draft guidance recommending against the use of Iluvien fluocinolone acetonide intravitreal impla...

FDA to review Alimera's Iluvien

Alimera Sciences Inc. (NASDAQ:ALIM) and partner pSivida Corp. (NASDAQ:PSDV; ASX:PVA) said FDA accepted for review a resubmitted NDA from Alimera for Iluvien fluocinolone acetonide intravitreal implant...

Matching PubMed Articles

Incorporation of anti-inflammatory agent into calcium hydroxide pulp capping material: An in vitro study of physical and mechanical properties.

The aims of this study were to investigate the release of fluocinolone acetonide from an experimental pulp capping material containing fluocinolone acetonide (PCFA) and compare some physical and mecha...

Long-term follow-up of patients treated with multiple fluocinolone acetonide implants for noninfectious uveitis.

PURPOSE: To evaluate long-term outcomes in eyes undergoing exchange of fluocinolone acetonide intravitreal implants for noninfectious uveitis. METHODS: In this retrospective case series, chart review...

Combined use of algorithms for peak picking, peak tracking and retention modelling to optimize the chromatographic conditions for liquid chromatography-mass spectrometry analysis of fluocinolone acetonide and its degradation products.

A strategy for rapid optimization of liquid chromatography column temperature and gradient shape is presented. The optimization as such is based on the well established retention and peak width models...

Short- and long-term safety assessment of a two-compound ointment containing calcipotriene/betamethasone dipropionate (Taclonex/Daivobet/Dovobet ointment): hypothalamic-pituitary-adrenal axis function in patients with psoriasis vulgaris.

The two-compound ointment (Taclonex/Daivobet/Dovobet ointment) combining calcipotriene 50 microg/g and betamethasone 0.5 mg/g (as dipropionate) is very effective in the treatment of psoriasis vulgaris...

Homogeneity study of ointment dosage forms by infrared imaging spectroscopy.

Ointment dosage forms are semi-solid preparations intended for local or transdermal delivery of active substances usually for application to the skin and it is important that they present a homogeneou...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement